Log In
Print this Print this

tafenoquine (SB 252263, WR-238605)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionSynthetic analog of primaquine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationMalaria
Indication DetailsPrevent malaria; Treat and prevent relapse of Plasmodium vivax malaria
Regulatory Designation U.S. - Breakthrough Therapy (Treat and prevent relapse of Plasmodium vivax malaria)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today